GCM
ELV icon

Gunderson Capital Management’s Elevance Health ELV Stock Holding History

Gunderson Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,734
Closed -$719K – 49
2020
Q2 		$719K Buy
2,734
+404
+17% +$108K 0.58% 46
2020
Q1 		$529K Buy
+2,330
New +$635K 0.73% 29
2019
Q2 		– Sell
-993
Closed -$285K – 61
2019
Q1 		$285K Buy
+993
New +$287K 0.25% 51

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gunderson Capital Management's ELV Position: Q3 2020 in Review

Gunderson Capital Management sold out of Elevance Health (ELV) in Q3 2020, closing a stake of 2,734 shares — an estimated $719K sold.

Gunderson Capital Management first reported a position in ELV in Q1 2019 and held it in 3 quarters. The position peaked at $719K in Q2 2020. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Gunderson Capital Management reported no remaining Elevance Health position as of Q3 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 2,734 Elevance Health shares in Q3 2020, an estimated $719K.
  • Gunderson Capital Management first reported a position in Elevance Health in Q1 2019 and held it in 3 quarters.
  • Gunderson Capital Management's Elevance Health position peaked at $719K in Q2 2020.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Gunderson Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.